LSP 5
Key Facts
- Status
Active
- Launch
2014
- Size
250M EUR
- SFDR classification
-
Do You Want to Learn More?
We are eager to explore how we can achieve great things together.
Half-year Report 2025
Active
2014
250M EUR
-
We are eager to explore how we can achieve great things together.
Company | Sector | Market | Entry | Exit |
|---|---|---|---|---|
| Aelin Therapeutics | Life Sciences | Belgium | 2017 | 2023 |
| Cardior | Life Sciences | Germany | 2017 | 2024 |
| Eloxx Pharma | Life Sciences | United States | 2017 | - |
| eTheRNA | Life Sciences | Belgium | 2016 | - |
| ImCheck | Life Sciences | France | 2017 | - |
| Immunic | Life Sciences | Germany | 2016 | - |
| Kuros | Life Sciences | Switzerland | 2015 | 2024 |
| Luxendo | Life Sciences | Germany | 2015 | 2017 |
| Neuravi | Life Sciences | Ireland | 2015 | 2017 |
| Nouscom | Life Sciences | Switzerland | 2015 | - |
| ONWARD | Life Sciences | Netherlands | 2016 | - |
| Orphazyme | Life Sciences | Denmark | 2017 | - |
| OxThera | Life Sciences | Sweden | 2016 | - |
| Pharvaris | Life Sciences | Germany | 2016 | - |
| Rainier Therapeutics | Life Sciences | Netherlands | 2016 | 2020 |
| Simplify Medical | Life Sciences | United States | 2017 | 2021 |
| ViCentra | Life Sciences | Netherlands | 2016 | - |